GM2 activator protein inhibits platelet activating factor signaling in rats

Biochemical and Biophysical Research Communications

Volumn 385, Issue 4, 2009, Pages 576-580

  Rigat, Brigitte ^a   Yeger, Herman ^b,c   Shehnaz, Darakhshanda ^a   Mahuran, Don ^a,c  

^a Research Institute   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

GM2AP; Inflammatory diseases; Lysosomal lipid binding protein; Necrotizing enterocolitis; PAF; Zonula Occludens 1

Indexed keywords

GANGLIOSIDE GM2 ACTIVATOR PROTEIN; RECOMBINANT PROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; G(M2) ACTIVATOR PROTEIN; MALE; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67249138682     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.116     Document Type: Article

References (25)

1. Prescott S.M., Zimmerman G.A., Stafforini D.M., and McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69 (2000) 419-445
2. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
3. Caplan M.S., Simon D., and Jilling T. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin. Pediatr. Surg. 14 (2005) 145-151
4. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 202 (2004) 145-156
5. Hsueh W., Gonzalez-Crussi F., and Arroyave J.L. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. Faseb J. 1 (1987) 403-405
6. Lin P.W., Nasr T.R., and Stoll B.J. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin. Perinatol. 32 (2008) 70-82
7. Knezevic I.I., Predescu S.A., Neamu R.F., Gorovoy M.S., Knezevic N.M., Easington C., Malik A.B., and Predescu D.N. Tiam1 and Rac1 are required for PAF-induced endothelial junctional disassembly and increase in vascular permeability. J. Biol. Chem. 284 (2009) 5381-5394
8. 2+ signalling in inflammatory neutrophils: implications for rheumatoid arthritis (Review). Int. J. Mol. Med. 1 (1998) 485-490
9. Min J.H., Jain M.K., Wilder C., Paul L., Apitz-Castro R., Aspleaf D.C., and Gelb M.H. Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase. Biochemistry 38 (1999) 12935-12942
10. Karabina S.A., and Ninio E. Plasma PAF-acetylhydrolase: an unfulfilled promise?. Biochim. Biophys. Acta 1761 (2006) 1351-1358
11. Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim. Biophys. Acta 1761 (2006) 1359-1372
12. Smiljanic-Georgijev N., Rigat B., Xie B., Wang W., and Mahuran D.J. Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay. Biochim. Biophys. Acta 1339 (1997) 192-202
13. Wright C.S., Mi L.Z., Lee S., and Rastinejad F. Crystal structure analysis of phosphatidylcholine-GM2-activator product complexes: evidence for hydrolase activity. Biochemistry 44 (2005) 13510-13521
14. Mahuran D.J. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein. Biochim. Biophys. Acta 1393 (1998) 1-18
15. Kolter T., and Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21 (2005) 81-103
16. M2 gangliosidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (1995), McGraw-Hill, New York 2839-2879
17. Rigat B., Reynaud D., Smiljanic-Georgijev N., and Mahuran D. The GM2 activator protein, a novel inhibitor of platelet-activating factor. Biochem. Biophys. Res. Commun. 258 (1999) 256-259
18. Rigat B., Wang W., Leung A., and Mahuran D.J. Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein. Biochemistry 36 (1997) 8325-8331
19. M2 activator is independent of a mannose-6-phosphate signal. J. Biol. Chem. 272 (1997) 5199-5207
20. Gonzalez-Crussi F., and Hsueh W. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am. J. Pathol. 112 (1983) 127-135
21. Klima H., Klein A., van Echten G., Schwarzmann G., Suzuki K., and Sandhoff K. Over-expression of a functionally active human GM2-activator protein in Escherichia coli. Biochem. J. 292 Pt 2 (1993) 571-576
22. Hopman A.H., Ramaekers F.C., and Speel E.J. Rapid synthesis of biotin-, digoxigenin-, trinitrophenyl-, and fluorochrome-labeled tyramides and their application for in situ hybridization using CARD amplification. J. Histochem. Cytochem. 46 (1998) 771-777
23. Henig N.R., Aitken M.L., Liu M.C., Yu A.S., and Henderson Jr. W.R. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. Am. J. Respir. Crit. Care Med. 162 (2000) 523-527
24. Kasperska-Zajac A., Brzoza Z., and Rogala B. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. Inflammation 31 (2008) 112-120
25. Desnick R.J. Enzyme replacement and enhancement therapies for lysosomal diseases. J. Inherit. Metab. Dis. 27 (2004) 385-410